Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial membrane components of oral bacteria and Candida species represent a broad class of structural and functional molecules essential for the survival and pathogenicity of the oral microbiota. In bacteria such as Porphyromonas gingivalis and Streptococcus mutans, these include peptidoglycan, lipopolysaccharides (LPS), and various membrane-bound proteins that facilitate adhesion and biofilm formation (NIH, 2023). In fungal species like Candida albicans, the membrane is characterized by the presence of ergosterol, which maintains fluidity and integrity, and cell wall components like beta-glucans and chitin (Journal of Fungi, 2021). These components are critical targets for antimicrobial agents; for instance, chlorhexidine acts by non-specifically disrupting bacterial cell membranes, while polyene antifungals like nystatin and amphotericin B bind specifically to ergosterol to create lethal pores (StatPearls, 2023). Targeting these structures is vital in treating oral infections such as periodontitis, dental caries, and oral candidiasis, although challenges include the potential for oral dysbiosis and the development of antimicrobial resistance (Frontiers in Microbiology, 2022). Furthermore, these membrane components often act as pathogen-associated molecular patterns (PAMPs) that trigger host immune responses through Toll-like receptors (PubMed, 2020). The integrity of these membranes is also a target for various antiseptic mouthwashes containing cetylpyridinium chloride or essential oils (Cochrane, 2017). Understanding the specific composition of these membranes allows for the development of more targeted therapies that minimize damage to the host healthy tissues.
Disruption of lipid bilayer integrity, inhibition of cell wall polymer synthesis, or binding to membrane sterols to induce pore formation and cytoplasmic leakage.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial membrane components of oral bacteria and Candida species.